medical device guru

Cardiovascular / Cardiology
Adagio Medical Raises $42.5 Million In Series E Financing
Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS™), today announced that it has closed a $42.5 million Series E equity financing.  Proceeds from the financing will be used...
November 16, 2020
Cardiovascular / Cardiology
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or $225.00 per share in cash. The transaction was unanimously approved by both the...
October 21, 2020
Cardiovascular / Cardiology
Livmor wins FDA clearance for continuous heart monitoring wearable
LIVMOR, Inc., a leading digital health solutions company, announced today that the Company received FDA 510(k) clearance for the LIVMOR Halo™ AF Detection System, a physician-prescribed wearable solution that provides continuous monitoring of pulse rhythms for the detection of atrial fibrillation...
October 16, 2020
Cardiovascular / Cardiology
J&J’s Biosense Webster gets FDA Nod for Ablation Catheter for Atrial Fibrillation
Johnson & Johnson Medical Devices Companies today announced the United States Food and Drug Administration (FDA) approval of Biosense Webster, Inc.’s THERMOCOOL SMARTTOUCH SF Ablation Catheter for the treatment of persistent atrial fibrillation (persistent AF). The approval is based on...
October 6, 2020
Cardiovascular / Cardiology
Avinger Receives FDA Clearance of Ocelaris Next Generation Image-guided CTO Crossing System
Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food &...
September 11, 2020
Cardiovascular / Cardiology
Medtronic Tricuspid Valve Replacement Device Wins FDA Breakthrough Status
Medtronic, a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) system in patients with severe, symptomatic tricuspid regurgitation, a...
September 9, 2020
Cardiovascular / Cardiology
CryoLife Acquires Ascyrus Medical
CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has acquired Ascyrus Medical LLC.  Ascyrus is a Florida-based, privately-held developer of the Ascyrus Medical Dissection Stent, the world’s first aortic arch remodeling...
September 3, 2020
Cardiovascular / Cardiology
Philips to Acquire Intact Vascular for $275M
Royal Philips, a global leader in health technology, today announced that it has signed an agreement to acquire Intact Vascular, Inc., a U.S.-based developer of medical devices for minimally-invasive peripheral vascular procedures. Intact Vascular will enhance Philips’ image-guided therapy portfolio,...
August 28, 2020
Cardiovascular / Cardiology
RapidAI Receives FDA Clearance of Rapid LVO For Identification of Suspected Large Vessel Occlusions
RapidAI, the worldwide leader in advanced imaging for stroke, today announced that Rapid LVO has received Food and Drug Administration (FDA) clearance for detecting suspected LVOs (Large Vessel Occlusions). Rapid LVO helps physicians speed up triage or transfer decision-making. Working...
August 13, 2020
1 2 3 24